Sponsor

Saskatchewan Health Authority - Regina Area

Clinical research sponsor

Published trials6
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

6 shown
Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)NCT06580873 · lead sponsor · 2024-09-30
NOT_YET_RECRUITING
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyNCT03549312 · lead sponsor · 2018-02-01
UNKNOWN
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided BiopsyNCT02488096 · lead sponsor · 2015-12-01
COMPLETED
Randomized Controlled Trial: Induction of Labour of Obese Women With Dinoprostone or Single Balloon CatheterNCT01962831 · lead sponsor · 2013-10-01
COMPLETED
Syphilis and HIV Point of Care Testing (POCT) in SaskatchewanNCT05863117 · collaborator · 2023-02-01
UNKNOWN
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety PersonnelNCT05530642 · collaborator · 2020-09-22
UNKNOWN

Sponsor roles

lead sponsor4
collaborator2

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.